Priority Date: 26.01.12 (GB 20120001298)

THERAPEUTIC USE OF ACTIVATORS OF ZINC FINGER PROTEIN GLI3

  • Application ID: EP13702948
  • Status: EXAMINATION IN PROGRESS

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 11 - 50 employees
Company dna kailuweit and uhlemann
operating since 1990
Headquarter in Dresden and 1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Kailuweit & Uhlemann is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 170 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 26.01.2012 - Priority Date (GB 20120001298)
  • 01.08.2013 - Publication A1 (WO2013110749)
  • 03.12.2014 - Publication A1 (EP2806884)

IPC Classification